Trademark applications and grants for Tg Therapeutics Inc. Tg Therapeutics Inc has 19 trademark applications. The latest application filed is for "BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV"
Patent Application | Date |
---|---|
TRIPLE COMBINATION TO TREAT B-CELL MALIGNANCIES 20220143026 - 17/525731 WEISS; Michael S. ;   et al. | 2022-05-12 |
COMBINATION OF ANTI-CD20 ANTIBODY, P13 KINASE-DELTA SELECTIVE INHIBITOR, AND BTK INHIBITOR TO TREAT B-CELL PROLIFERATIVE DISORDERS 20210169878 - 17/175184 WEISS; Michael S. ;   et al. | 2021-06-10 |
Combination of Anti-CD20 Antibody and PI3 Kinase Selective Inhibitor 20200323981 - 16/946585 Weiss; Michael S. ;   et al. | 2020-10-15 |
COMBINATION OF AN ANTI-CD20 ANTIBODY, PI3 KINASE-DELTA INHIBITOR, AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY FOR TREATING HEMATOLOGICA 20190247399 - 16/331407 Weiss; Michael S. ;   et al. | 2019-08-15 |
COMBINATION OF ANTI-CD20 ANTIBODY, P13 KINASE-DELTA SELECTIVE INHIBITOR, AND BTK INHIBITOR TO TREAT B-CELL PROLIFERATIVE DISORDE 20190175592 - 16/304590 WEISS; Michael S. ;   et al. | 2019-06-13 |
SEC | 0001001316 | TG THERAPEUTICS, INC. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.